ArticleCureus2025
Not Just Sjögren's: A Rare Life-Threatening Manifestation in a Pediatric Patient.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Macrophage activation syndrome (MAS), a severe hyperinflammatory state within the spectrum of hemophagocytic lymphohistiocytosis (HLH), is a life-threatening complication most commonly associated with rheumatologic disorders such as systemic juvenile idiopathic arthritis. Pediatric Sjögren's disease, however, is a rare and underrecognized etiology. We present the case of an eight-year-old female patient with no prior medical history who developed MAS in the setting of newly diagnosed Sjögren's disease, notably without classical sicca symptoms. Her course was marked by progressive systemic inflammation, multiorgan involvement, and laboratory findings suggestive of HLH/MAS. Diagnosis was confirmed through bone marrow biopsy and rheumatologic evaluation, and she responded favorably to immunosuppressive therapy with anakinra and corticosteroids. This case highlights the diagnostic challenges of MAS in atypical pediatric presentations and underscores the need for broader clinical suspicion in cytokine storm syndromes, particularly when established classification criteria are lacking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.